Search Within

Erin M McGovern

Formats
  1. Meeting Abstract (14)
  2. Journal Article (11)
Groups
  1. Adult Leukemia (25)
  2. Center for Hematologic Malignancies (25)
  3. Department of Medicine (25)
  4. Hematologic Malignancies, Division of (25)
  5. Executive Committee, Center for Hematologic Malignancies (17)
  6. GSK Faculty (17)

More Groups

People
  1. Ross Levine (17)
  2. Noushin Rahnamay Farnoud (16)
  3. Raajit Rampal (15)
  4. Minal Patel (13)
  5. Juan Arango Ossa (9)
  6. Christopher Famulare (8)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (1)
  5. 2020 (4)
  6. 2019 (7)

More Years

Publications
  1. Blood (16)
  2. Blood Advances (2)
  3. Clinical Cancer Research (2)
  4. American Journal of Hematology (1)
  5. Cancer Cell (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. American Association for Cancer Research (2)
  3. Amer Soc Clinical Investigation Inc (1)
  4. Cell Press (1)
  5. Elsevier Ltd (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Early detection and molecular characterization of therapy-related leukemia in children reveals patterns of disease transformation and guides future surveillance protocols
    Meeting Abstract

    Spitzer, B.; Gundem, G.; Farnoud, N.; Millard, N.; McGovern, E.; Patel, M.; Levine, M.; Medina, J.; Zhou, Y.; Arango Ossa, J. E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Evaluation of combination tagraxofusp (SL-401) and hypomethylating agent (HMA) therapy for the treatment of chronic myelomonocytic leukemia (CMML)
    Meeting Abstract

    Krishnan, A.; Li, B.; Pagane, M.; McGovern, E.; Stone-Molloy, Z.; Chen, J.; Brooks, C.; Levine, R. L.; Rampal, R. K.
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Dual targeting of oncogenic activation and inflammatory signaling increases therapeutic efficacy in myeloproliferative neoplasms
    Journal Article

    Kleppe, M.; Koche, R.; Zou, L.; van Galen, P.; Hill, C. E.; Dong, L.; De Groote, S.; Papalexi, E.; Hanasoge Somasundara, A. V.; Cordner, K.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save